Elekta stock faces heavy short interest as shares hover in the mid 50s SEK
Published on 08/25/2026 at 19:59 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Elekta (SE0000163628) stock traded at 55.40 SEK on August 25, 2026, in estimated real-time on Cboe Europe, modestly below its previous close of 55.60 SEK as investors digest persistently high short interest in the Swedish radiotherapy specialist. Per a recent market overview, the shares show a year-to-date gain of 1.46% despite segment volatility, while one sector snapshot listed a reference level of 53.32 SEK, underscoring that the current price is still above some recent supports. Consensus data cited in the same overview point to an average target price of 59.82 SEK, implying upside of 7.59% from the last closing level reported.
Short sellers build new positions
Fresh disclosures on August 25, 2026, show that hedge fund Ilex Capital Partners has initiated a public short position of 0.53% of Elekta’s share capital, crossing the 0.5% threshold that triggers mandatory reporting in Sweden. The fund’s prior holding was below that reporting threshold, meaning the disclosed position marks an increase in its bearish exposure. At the same time, aggregate data indicate that 13.69% of Elekta’s outstanding share capital is currently sold short, reflecting a sizable bet from bearish investors and creating a potential source of future buying pressure if positions are covered.
The short-interest landscape is not static: another market update on August 25, 2026, noted that AQR Capital Management reduced its own position below the 0.5% public-reporting level, so it no longer appears among the disclosed short sellers. Even with that reduction, the number of publicly declared short sellers remains high, with nine such investors still reported. This mix of a new 0.53% position from Ilex Capital Partners and the exit of at least one previously visible short seller underlines that Elekta remains a crowded name on the short side, yet with shifting players.
Price level and consensus context
The 55.40 SEK quote recorded on August 25, 2026, for Elekta shares sits modestly above the 53.32 SEK sector-review level highlighted in a same-day market snapshot, indicating that the stock is trading above this referenced mark even after the minor intraday decline. In percentage terms, a move from 53.32 SEK to 55.40 SEK corresponds to a gain of 3.9%, illustrating that the shares have recovered from that reference point despite the pressure from short sellers. The small setback of 0.36% from the previous 55.60 SEK close therefore takes place against a backdrop of a modest positive trend over the last stretch of trading days.
Analyst consensus figures included in the same overview show an average recommendation to hold the stock, based on contributions from 14 analysts. The average target price stands at 59.82 SEK versus the recent 55.60 SEK closing price cited in the data, which corresponds to an implied upside of 7.59%. Numerically, this gap of 4.22 SEK between the current level and the average target highlights that, at least on paper, the consensus view sees room for gains, even as a significant portion of the share capital remains sold short. For investors, this tension between a hold-rated consensus with single-digit implied upside and a double-digit percentage of the float shorted is a central feature of the current Elekta equity story.
Recent shifts among short sellers
The market statistics released on August 25, 2026, show that the number of declared short sellers in Elekta has reached ten when counting both the newly disclosed Ilex Capital Partners stake and the other funds already above the 0.5% threshold. Yet a separate update the same day reports only nine public short sellers after AQR Capital Management dropped below the disclosure limit. The difference reflects the dynamic nature of the short register during the session: as new disclosures are logged and existing ones are reduced, the precise count at any given moment can move by one or two funds while the aggregate short ratio, at 13.69% of share capital, remains elevated.
For Elekta’s share price, such a high aggregate short position means that news on fundamentals, regulatory developments, or large contract wins could trigger substantial covering activity. If a piece of positive news caused just a fraction of the 13.69% of shorted shares to be bought back in a short period, the resulting demand could significantly affect the price given the stock’s normal liquidity. Conversely, negative surprises on earnings or margins would tend to validate the short thesis and could encourage further short selling, especially if the stock were to break below recent levels such as 53.32 SEK on increased volume.
Earnings backdrop and valuation signals
While the day’s disclosures focus on positioning rather than new financial statements, the current consensus and price levels implicitly reference Elekta’s most recently reported financial year and interim results, which shape analysts’ target prices and ratings. The existence of a 59.82 SEK average target with a hold recommendation and 14 contributing analysts indicates that the market has access to a fairly detailed model of Elekta’s revenue growth, margins, and cash flow, even if those precise figures are not included in the short-interest updates. Based on the 7.59% spread between the recent closing price and the consensus target, Elekta is viewed as modestly undervalued by this group of analysts rather than deeply discounted or richly valued.
This positioning suggests that Elekta is not being treated purely as a turnaround play or a high-growth outlier, but as a company where execution on existing guidance and project backlog is crucial. If upcoming quarterly results show that revenue growth and profitability are tracking analyst expectations or exceeding them, the current 59.82 SEK target could be revised upward, reducing the relative weight of the 13.69% short-interest stake. If, however, margins compress or order intake weakens, both target prices and ratings could be downgraded, potentially reinforcing the short case and putting further pressure on the 55.40 SEK trading zone.
Radiotherapy systems as a core business driver
Elekta’s core business revolves around advanced radiotherapy and radiosurgery systems used in the treatment of cancer and other serious diseases. The company designs and manufactures linear accelerators, stereotactic radiosurgery platforms, and integrated software solutions that help clinicians plan and deliver precisely targeted radiation doses. Hospitals and cancer centers invest in these systems to increase treatment accuracy, reduce exposure to healthy tissue, and improve patient throughput, particularly in regions where demand for radiotherapy is rising faster than existing capacity.
Beyond hardware, Elekta offers treatment-planning software and oncology information systems that connect imaging, planning, and delivery into a single workflow. This combination supports multi-year service and software-upgrade revenue, which can contribute to recurring income once a system is installed. For investors, adoption of new platforms, expansion into emerging markets, and the mix between equipment sales and software or services are all key variables that will influence future earnings and determine whether the current 7.59% discount to the average target price narrows or widens over time.
Elekta stock and current trading setup
As of August 25, 2026, Elekta stock is quoted at 55.40 SEK in estimated real-time on Cboe Europe, with the last confirmed close at 55.60 SEK, indicating a mild intraday decline of 0.36% alongside a positive year-to-date gain of 1.46%. This places the shares a few percent above a referenced 53.32 SEK level in sector data and several kronor below the 59.82 SEK analyst target that implies 7.59% upside from the latest closing price. Against that backdrop, the disclosure that 13.69% of the company’s share capital is currently sold short, and that at least one new fund has crossed the 0.5% reporting threshold with a 0.53% position, underscores that Elekta remains a contested name on the Stockholm market.
Read more
Short-selling update on Elekta
Investor Relations
Fact box
Company: Elekta AB
ISIN: SE0000163628
Ticker: EKTAB
Exchange: Nasdaq Stockholm
Price (as of August 25, 2026, 3:38 p.m. CET): 55.40 SEK
Market cap: value corresponding to 55.40 SEK per share (as of August 25, 2026)
Sector / Industry: Medical technology / Oncology equipment
Index membership: Stockholm benchmark index
